SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 9, 2011
APOLLO MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
000-25809
|
|
20-8046599
|
|
(State or Other Jurisdiction
|
|
(Commission File
|
|
(I.R.S. Employer
|
|
of Incorporation)
|
|
Number)
|
|
Identification Number)
|
450 N. Brand Blvd., Suite 600, Glendale, CA 91203
(Address of principal executive offices) (zip code)
(818) 396-8050
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Adrian Vazquez, M.D., resigned his positions as Chairman of the Board, President and a director of Apollo Medical Holdings, Inc. (the “Company”), in each case effective December 9, 2011. The resignation is not a result of any disagreement between Dr. Vazquez and the Company. Warren Hosseinion, M.D., the Company’s Chief Executive Officer, will be performing the duties of Chairman of the Board and President on an interim basis. The information with respect to Dr. Hosseinion in the Company’s Form 10-K filed on May 16, 2011 is incorporated herein by this reference.